Navigation Links
Agility Clinical, Inc., a Specialty Contract Research Organization is Formed
Date:5/30/2012

CARLSBAD, Calif., May 30, 2012 /PRNewswire/ -- The formation of a new Contract Research Organization (CRO), Agility Clinical, Inc., was announced today.  Agility will focus on providing customized clinical research and consulting services to small and virtual biotechnology, specialty pharma, medical device and diagnostic companies.  The Company was formed by David F. Hale, Chairman and CEO of Hale BioPharma Ventures, LLC.

According to Hale, "Agility's mission is to provide services to small and virtual biopharma companies, with a focus on treatments or diagnoses for children and orphan diseases.  While Agility will provide traditional CRO services, companies may also choose from a menu of services that addresses their specific needs.  The executive management team is comprised of individuals with strong experience in all phases and functional areas of clinical trials."

Hale, who has been a key figure in the Southern California life sciences industry for over 25 years, has been involved as founder, CEO or chairman of several companies, including Hybritech, Inc., Gensia, Inc., Viagene, Inc., Santarus, Inc., Somaxon Pharmaceuticals, SkinMedica, Inc., Neurelis, Inc., and a number of others.  Hale will serve as Chairman of the Board and has recruited an executive management team of industry veterans who have significant experience in the design, execution, and completion of clinical trials, including Ellen Morgan, Marilyn Carlson, DMD, MD, Elizabeth Ludington, PhD, Kristi Clark, MBA, and Ali Sadighian.

Morgan, who will serve as CEO, brings 30 years of industry experience to Agility.  She co-founded and was CEO and chairman of Synteract, Inc., a California-based CRO which grew to over 300 employees, and provided clinical services to hundreds of companies. She is also founder and CEO of the first non-profit CRO, Public Health Alliance for Clinical Trials (PHACT), whose mission is to conduct clinical trials for neglected diseases in developing countries.

"The name Agility Clinical was chosen to reflect our corporate culture and mission.  Small and virtual companies need service providers that are agile, affordable, experienced, and dedicated," said Morgan.  "Agility will provide exceptional service while keeping costs reasonable.  At Agility, we will not only be able to support biopharma with the expertise and dedication they require, but our focus on pediatric and orphan drug studies will help the patients with the greatest need."

Agility has established operations in Carlsbad, CA. Contact:

Ali Sadighian 760-520-0395asadighian@agility-clinical.com www.agility-clinical.com


'/>"/>
SOURCE Agility Clinical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. C3i Inc to Provide Full-Service Technology Support and Oracle Clinical, Oracle Remote Data Capture Business Process Outsourcing to XBiotech, Inc
2. RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership
3. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
4. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
5. CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)
6. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2008 Washington State Technology Fast 50 for 5th Time in Past 7 Years
7. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
8. [video] Dr. Tony Milici, Chairman and CEO of GeneThera, Inc., Discusses Worldwide Rights to E.Coli Vaccine on WallSt.nets 3-Minute Press Show
9. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
10. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 On Thursday, ... session at 5,817.69, down 0.07%; the Dow Jones Industrial ... the S&P 500 closed at 2,345.96, marginally dropping 0.11%. ... closed in green, 4 sectors finished in red, and ... Stock-Callers.com has initiated reports coverage on the following Biotechnology ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
(Date:3/23/2017)... ... ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking event company in ... the world, such as Illumina, HP and Qualcomm, and is ranked #1 in its category ... due to its new team building format, a way for teams to not only interact ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):